Biotech: Time For A Pause To Start 2026
Source: SeekingAlpha
2026-01-02 06:52:42 ET
The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the administration in April. This ETF is up around 20% from my last article on it early in October, when I was still bullish on the sector....
Read the full article on Seeking Alpha
For further details see:
Biotech: Time For A Pause To Start 2026
Avidity Biosciences Inc.
NASDAQ: RNA
RNA Trading
-0.3% G/L:
$14.78 Last:
277,962 Volume:
$14.82 Open:
RNA Latest News
February 27, 2026 09:19:00 am
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
February 26, 2026 04:02:00 pm
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 23, 2026 08:00:00 am
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
RNA Stock Data
$10,978,987,941
124,608,839
0.38%
98
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
